Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 2, Open-Label 20-Week Study to Evaluate the Safety and Efficacy of Setmelanotide in Subjects With Hypothalamic Obesity

Next Previous
X
Search
Trial Profile

A Phase 2, Open-Label 20-Week Study to Evaluate the Safety and Efficacy of Setmelanotide in Subjects With Hypothalamic Obesity

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 25 Nov 2024

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Setmelanotide (Primary)
  • Indications Obesity
  • Focus Proof of concept; Therapeutic Use
  • Sponsors Rhythm

    • Most Recent Events

    • 18 Nov 2024 According to a Rhythm media release, A cross-sectional analysis of 50 patients aged 2 to 17 years, with rare MC4R pathway diseases who participated in one of five different clinical trials of setmelanotide, including this one, was presented at European Society for Paediatric Endocrinology (ESPE 2024), held Nov 16-18, 2024, at Liverpool, UK.
    • 05 Nov 2024 According to a Rhythm Health media release, data from the extension phase of the this trial will be presented During The Obesity Societys ObesityWeek conference in San Antonio in November 2024.
    • 29 Apr 2024 According to a Rhythm Health media release, results from this study were published in the peer-reviewed journal The Lancet Diabetes & Endocrinology.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top